Table 1 Clinical data of the SLE patients.
Characteristics | Values | ||
---|---|---|---|
SLE | DLE | NC | |
Age (yrs) | 39.5 ± 10.1 | 38.7 ± 12.9 | 36.8 ± 9.7 |
Sex (F/M) | 107/3 | 30/1 | 53/2 |
Disease duration (yrs) | 5.73 ± 5.37 | 1.45 ± 1.19 | ND |
ESR (mm/h) | 44.2 ± 23.0 | 24.6 ± 18.7 | ND |
CRP (mg/L) | 21.67 ± 48.27 | 10.61 ± 11.70 | ND |
LN (with/without) | 63/47 | 0/31 | ND |
C3 (g/L) | 0.62 ± 0.31 | 0.70 ± 0.29 | ND |
C4 (g/L) | 0.13 ± 0.09 | 0.24 ± 0.19 | ND |
IgG (g/L) | 16.97 ± 0.72 | 12.10 ± 0.68 | ND |
IgA (g/L) | 3.13 ± 0.16 2 | 78 ± 0.21 | ND |
IgM (g/L) | 1.09 ± 0.10 | 1.07 ± 0.18 | ND |
Hb (g/L) | 108.30 ± 2.28 | 12.78 ± 2.56 | ND |
PLT (109/L) | 187.90 ± 11.08 | 200.04 ± 31.28 | ND |
WBC (109/L) | 5.57 ± 0.32 | 6.23 ± 1.62 | ND |
Anti-dsDNA (IU/mL) | 50.56 (6.91–778.45) | 30.17 (5.89–168.23) | ND |
SLEDAI | 8 (0–24) | ND | ND |